Literature DB >> 23986544

Risk factors for the development of gastrointestinal colonization with fluoroquinolone-resistant Escherichia coli in residents of long-term care facilities.

Jennifer H Han1, Joel Maslow, Xiaoyan Han, Sharon X Xie, Pam Tolomeo, Evelyn Santana, Lesley Carson, Ebbing Lautenbach.   

Abstract

BACKGROUND: The objective of this study was to assess risk factors for the development of fluoroquinolone (FQ)-resistant Escherichia coli gastrointestinal tract colonization in long-term care facility (LTCF) residents.
METHODS: A prospective cohort study was conducted from 2006 to 2008 at 3 LTCFs. Residents initially colonized with FQ-susceptible E. coli were followed by means of serial fecal sampling for new FQ-resistant E. coli colonization for up to 12 months or until discharge or death. A Cox proportional hazards regression model was developed to identify risk factors for new FQ-resistant E. coli colonization, with antibiotic and device exposures modeled as time-varying covariates.
RESULTS: Fifty-seven (47.5%) of 120 residents became newly colonized with FQ-resistant E. coli, with a median time to colonization of 57 days. Fecal incontinence (hazard ratio [HR], 1.78; 95% confidence interval [CI], 1.04-3.06; P = .04) was significantly associated with FQ-resistant E. coli acquisition. Receipt of amoxicillin-clavulanate (HR, 6.48; 95% CI, 1.43-29.4; P = .02) and the presence of a urinary catheter (HR, 3.81; 95% CI, 1.06-13.8; P = .04) during LTCF stay increased the risk of new FQ-resistant E. coli colonization.
CONCLUSIONS: Acquisition of FQ-resistant E. coli was common, with nearly half of LTCF residents developing new FQ-resistant E. coli colonization. Further studies are needed on interventions to limit the emergence of FQ-resistant E. coli in LTCFs.

Entities:  

Keywords:  Escherichia coli; fluoroquinolones; long-term care; resistance; risk factors

Mesh:

Substances:

Year:  2013        PMID: 23986544      PMCID: PMC3883173          DOI: 10.1093/infdis/jit471

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.

Authors:  P Richard; M H Delangle; F Raffi; E Espaze; H Richet
Journal:  Clin Infect Dis       Date:  2000-12-11       Impact factor: 9.079

2.  Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center.

Authors:  R R Muder; C Brennen; A M Goetz; M M Wagener; J D Rihs
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

3.  Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance.

Authors:  Melissa Viray; Darren Linkin; Joel N Maslow; Donald D Stieritz; Lesley S Carson; Warren B Bilker; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2005-01       Impact factor: 3.254

4.  New acquisition of antibiotic-resistant organisms in skilled nursing facilities.

Authors:  Jay Fisch; Bonnie Lansing; Linda Wang; Kathleen Symons; Kay Cherian; Sara McNamara; Lona Mody
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

5.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

6.  Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.

Authors:  W V Kern; M Oethinger; A S Jellen-Ritter; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

7.  Antimicrobial use in long-term-care facilities. SHEA Long-Term-Care Committee.

Authors:  L E Nicolle; D W Bentley; R Garibaldi; E G Neuhaus; P W Smith
Journal:  Infect Control Hosp Epidemiol       Date:  2000-08       Impact factor: 3.254

Review 8.  The burden of infection in long-term care.

Authors:  L J Strausbaugh; C L Joseph
Journal:  Infect Control Hosp Epidemiol       Date:  2000-10       Impact factor: 3.254

9.  Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.

Authors:  Ebbing Lautenbach; Neil O Fishman; Joshua P Metlay; Xiangqun Mao; Warren B Bilker; Pam Tolomeo; Irving Nachamkin
Journal:  J Infect Dis       Date:  2006-05-31       Impact factor: 5.226

10.  Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility.

Authors:  Joel N Maslow; Betsy Lee; Ebbing Lautenbach
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  10 in total

1.  Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms.

Authors:  Joyce Wang; Betsy Foxman; Lona Mody; Evan S Snitkin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-12       Impact factor: 11.205

Review 2.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

3.  Long-Term Carriage of Ciprofloxacin-Resistant Escherichia coli Isolates in High-Risk Nursing Home Residents.

Authors:  Miriam D Ismail; Ting Luo; Sara McNamara; Bonnie Lansing; Evonne Koo; Lona Mody; Betsy Foxman
Journal:  Infect Control Hosp Epidemiol       Date:  2016-01-19       Impact factor: 3.254

Review 4.  Expanding the statistical toolbox: analytic approaches for cohort studies with healthcare-associated infectious outcomes.

Authors:  Rebecca A Pierce; Justin Lessler; Aaron M Milstone
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

5.  Epidemiology and characteristics of Escherichia coli sequence type 131 (ST131) from long-term care facility residents colonized intestinally with fluoroquinolone-resistant Escherichia coli.

Authors:  Jennifer H Han; Charles Garrigan; Brian Johnston; Irving Nachamkin; Connie Clabots; Warren B Bilker; Evelyn Santana; Pam Tolomeo; Joel Maslow; Janice Myers; Lesley Carson; Ebbing Lautenbach; James R Johnson
Journal:  Diagn Microbiol Infect Dis       Date:  2016-11-28       Impact factor: 2.803

6.  Risk factors for infection with Escherichia coli in nursing home residents colonized with fluoroquinolone-resistant E. coli.

Authors:  Sara Manning; Ebbing Lautenbach; Pam Tolomeo; Jennifer H Han
Journal:  Infect Control Hosp Epidemiol       Date:  2015-05       Impact factor: 3.254

Review 7.  Examining the relationship between multidrug-resistant organism acquisition and exposure to antimicrobials in long-term care populations: a review.

Authors:  Michele L Shaffer; Erika M C D'Agata; Daniel Habtemariam; Susan L Mitchell
Journal:  Ann Epidemiol       Date:  2016-09-23       Impact factor: 3.797

8.  Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.

Authors:  E Batard; M-A Vibet; S Thibaut; S Corvec; J Pivette; D Lepelletier; J Caillon; E Montassier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-26       Impact factor: 3.267

9.  Long-Term Care Facilities Are Reservoirs for Antimicrobial-Resistant Sequence Type 131 Escherichia coli.

Authors:  Mary J Burgess; James R Johnson; Stephen B Porter; Brian Johnston; Connie Clabots; Brian D Lahr; James R Uhl; Ritu Banerjee
Journal:  Open Forum Infect Dis       Date:  2015-02-17       Impact factor: 3.835

10.  Prevalence, Incidence, and Risk Factors for Intestinal Colonization Due to Fluoroquinolone-Resistant ST131 Escherichia coli: a Longitudinal Study in Highly Dependent, Long-Term Care Facility Residents.

Authors:  Elena Salamanca-Rivera; Lorena López-Cerero; Alvaro Pascual; Jesús Rodríguez-Baño; Jose Manuel Rodríguez-Martínez
Journal:  Microbiol Spectr       Date:  2022-08-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.